Everything by Chris.

Cars and Drivers

Should Tesla Be Worried About This $2 Billion Patent Suit?

May 2, 2018 Health and Healthcare

Can Esperion Therapeutics Go the Distance After This Report?

May 2, 2018 Technology

Why Stratasys Is One of Wednesday’s Biggest Earnings Losers

May 2, 2018 Health and Healthcare

Why Gilead Sciences Whiffed in Q1

May 2, 2018 Technology

Apple Does It Again With Q2 Earnings

May 1, 2018 Investing

Tuesday’s Biggest Winners and Losers in the S&P 500

May 1, 2018 Media

Facebook Breaks Into Dating: A Bad Break for Match

May 1, 2018 Casinos & Hotels

Meet the Top Vacation Destinations for Americans This Summer

May 1, 2018 Health and Healthcare

Why Karyopharm Is on the Move

May 1, 2018 Health and Healthcare

Will Gilead Sciences Earnings Get a Boost From a Collaboration?

May 1, 2018 Consumer Electronics

Can Apple Keep Up the Pace With Q2 Earnings?

May 1, 2018 Media

What to Expect When Snap Reports After the Close

May 1, 2018 Health and Healthcare

How Keytruda Saved Merck’s Q1

May 1, 2018 Health and Healthcare

How Much Pfizer Earnings Depend on a Few Brands

May 1, 2018 Companies and Brands

How Under Armour Managed to Pull Off a Decent Q1 Report

May 1, 2018 Investing

Monday’s Biggest Winners and Losers in the S&P 500

Apr 30, 2018 Health and Healthcare

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Apr 30, 2018 Services

Can Under Armour Kill It This Quarter?

Apr 30, 2018 Health and Healthcare

Evelo Announces Potential Pricing for IPO

Apr 30, 2018 Health and Healthcare

Why SteadyMed Shares Are Skyrocketing

Apr 30, 2018